The problems with anticancer therapy are resistance and toxicity. From 3000 Cisplatin
derivatives tested as antitumor agents, most of them have been rejected, due to toxicity. The …

Background Traditionally, within dose-finding clinical trials, treatment toxicity and tolerability
are assessed by clinicians. Research has shown that clinician reporting may have …

Simple Summary Peritoneal metastases (PMs), arising from gastric cancer (GC), are one of
the most common patterns of synchronous and metachronous dissemination and are …

Aims Gastric cancer with peritoneal involvement has a poor prognosis. Intraperitoneal (IP)
paclitaxel has shown promising results in these patients. However, this approach has only …

Methods: A search of PubMed and Google Scholar databases was performed for the terms
“Gastric Adenocarcinoma Peritoneal Carcinomatosis” for English articles published between …

腹膜转移是胃癌的主要致死原因. 近年来, 部分临床研究证实包含腹腔灌注化疗的综合治疗可
改善胃癌患者预后, 降低根治术后转移风险, 也可改善并延长已存在腹膜转移患者的生存时间 …

Introduction This is a phase 1, open-label, single-centre, uncontrolled, dose-escalation study
to evaluate the feasibility, tolerability and pharmacokinetic profiles of a single dose of …

Background Traditionally, within dose-finding clinical trials, treatment toxicity and tolerability
are assessed by clinicians. Research has shown that clinician reporting may have …

Gastric adenocarcinoma peritoneal carcinomatosis: a narrative review Page 1 Page 1 of 12
© Digestive Medicine Research. All rights reserved. Dig Med Res 2022;5:37 | https://dx.doi.org/10.21037/dmr-21-94 …

Introduction This is a phase 1, open-label, singlecentre, uncontrolled, dose-escalation study
to evaluate the feasibility, tolerability and pharmacokinetic profiles of a single dose of …